Cognitive Remediation Journal 2015, 4(1):3-18 | DOI: 10.5507/crj.2015.001

Animal Models of Schizophrenia with a Focus on Models Targeting NMDA Receptors

Svojanovská M., Stuchlík A.

Schizophrenia is a serious and often devastating disease, affecting approximately 1% of worldwide population. Animal models represent a suitable way for investigating serious brain diseases in preclinical research. Animal models of schizophrenia can be generally divided into several categories that include pharmacological, genetic and neurodevelopmental models. Pharmacological models are usually based on application of specific receptor ligands for neurotransmitters. Genetic models are created by genetic manipulations (mutations; often in laboratory mice). Neurodevelopmental models are induced by manipulations in early stages of life of the laboratory animal. They are manifested later in juvenile or adult age by phenotypes that are similar to schizophrenia symptoms. This review summarizes and discusses pharmacological models of schizophrenia based on application of NMDA receptor antagonists; furthermore, the study focuses on selected genetic and neurodevelopmental models.

Keywords: Schizophrenia, animal models, pharmacological models, genetic models, neurodevelopmental models, preclinical studies

Accepted: January 7, 2015; Published: March 31, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svojanovská M, Stuchlík A. Animal Models of Schizophrenia with a Focus on Models Targeting NMDA Receptors. Cogn. Remediat. J. 2015;4(1):3-18. doi: 10.5507/crj.2015.001.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abdul-Monim Z., Reynolds G.P., Neill J.C. (2003). "The Atypical Antipsychotic Ziprasidone, but Not Haloperidol, Improves Phencyclidine-Induced Cognitive Deficits in a Reversal Learning Task in the Rat." Journal of Psychopharmacology (Oxford, England) 17 (1): 57-65. Go to original source...
    2. Abdul-Monim Z., Reynolds G.P., Neill J.C. (2006). "The Effect of Atypical and Classical Antipsychotics on Sub-Chronic PCP-Induced Cognitive Deficits in a Reversal-Learning Paradigm." Behavioural Brain Research 169 (2): 263-73. Go to original source...
    3. Adler C.M., Malhotra A.K., Elman I., Goldberg T., Egan M., Pickar D., Breier A. (1999). "Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia." The American Journal of Psychiatry 156 (10): 1646-49. Go to original source...
    4. Ahlander M., Misane I., Schött P.A., Ogren S.O. (1999). "A Behavioral Analysis of the Spatial Learning Deficit Induced by the NMDA Receptor Antagonist MK-801 (dizocilpine) in the Rat." Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 21 (3): 414-26. Go to original source...
    5. Allen D.N., Frantom L.V., Strauss G.P., van Kammen D.P. (2005). "Differential Patterns of Premorbid Academic and Social Deterioration in Patients with Schizophrenia." Schizophrenia Research 75 (2-3): 389-97. Go to original source...
    6. Amitai N., Markou A. (2010). "Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced by Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in Schizophrenia." Biological Psychiatry 68 (1): 5-16. Go to original source...
    7. Amminger G.P., Schlögelhofer M., Lehner T., Looser Ott S., Friedrich M.H., Aschauer H.N. (2000). "Premorbid Performance IQ Deficit in Schizophrenia." Acta Psychiatrica Scandinavica 102 (6): 414-22. Go to original source...
    8. Andiné P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Mårtensson E., Sandberg M. (1999). "Characterization of MK-801-Induced Behavior as a Putative Rat Model of Psychosis." The Journal of Pharmacology and Experimental Therapeutics 290 (3): 1393-1408.
    9. Andreasen N.C. (1995). "Symptoms, Signs, and Diagnosis of Schizophrenia." Lancet 346 (8973): 477-81. Go to original source...
    10. Arvidsson L.E., Hacksell U., Nilsson J.L., Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstrom H. (1981). "8-Hydroxy-2-(di-N-Propylamino)tetralin, a New Centrally Acting 5-Hydroxytryptamine Receptor Agonist." Journal of Medicinal Chemistry 24 (8): 921-23. Go to original source...
    11. Ballard T.M., Pauly-Evers M., Higgins G.A., Ouagazzal A.M., Mutel V., Borroni E., Kemp J.A., BluethmannH., Kew J.N. (2002). "Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity." The Journal of Neuroscience 22 (15): 6713-23. Go to original source...
    12. Baron S.P., Wenger G.R. (2001). "Effects of Drugs of Abuse on Response Accuracy and Bias under a Delayed Matching-to-Sample Procedure in Squirrel Monkeys." Behavioural Pharmacology 12 (4): 247-56. Go to original source...
    13. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. (2003). "Ketamine-Induced Changes in Rat Behaviour: A Possible Animal Model of Schizophrenia." Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (4): 687-700. Go to original source...
    14. Bender C., de Olmos S., Bueno A., de Olmos J., Lorenzo A. (2010). "Comparative Analyses of the Neurodegeneration Induced by the Non-Competitive NMDA-Receptor-Antagonist Drug MK801 in Mice and Rats." Neurotoxicology and Teratology 32 (5): 542-50. Go to original source...
    15. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. (2000). "Antidepressant Effects of Ketamine in Depressed Patients." Biological Psychiatry 47 (4): 351-54. Go to original source...
    16. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A (1995). "Apoptosis and Necrosis: Two Distinct Events Induced, Respectively, by Mild and Intense Insults with N-Methyl-D-Aspartate or Nitric Oxide/superoxide in Cortical Cell Cultures." Proceedings of the National Academy of Sciences of the United States of America 92 (16): 7162-66. Go to original source...
    17. Boyce S., Rupniak N.M., Steventon M.J., Cook G., Iversen S.D. (1991). "Psychomotor Activity and Cognitive Disruption Attributable to NMDA, but Not Sigma, Interactions in Primates." Behavioural Brain Research 42 (2): 115-21. Go to original source...
    18. Bubenikova-Valesova V., Stuchlik A., Svoboda J., Bures J, Vales K. (2008). "Risperidone and Ritanserin but Not Haloperidol Block Effect of Dizocilpine on the Active Allothetic Place Avoidance Task." Proceedings of the National Academy of Sciences of the United States of America 105 (3): 1061-66. Go to original source...
    19. Castle D., Sham P., Murray R. (1998). "Differences in Distribution of Ages of Onset in Males and Females with Schizophrenia." Schizophrenia Research 33 (3): 179-83. Go to original source...
    20. Cliffe I.A., Brightwell C.I., Fletcher A., Forster E.A., Mansell H.L., Reilly Y., Routledge C., White A.C. (1993). "(S)-N-Tert-Butyl-3-(4-(2-Methoxyphenyl)-Piperazin-1-Yl)-2-Phenylpropanamide [(S)-WAY-100135]: A Selective Antagonist at Presynaptic and Postsynaptic 5-HT1A Receptors." Journal of Medicinal Chemistry 36 (10): 1509-10. Go to original source...
    21. Colwell C.S., Cepeda C., Crawford C., Levine M.S. (1998). "Postnatal Development of Glutamate Receptor - Mediated Responses in the Neostriatum." Developmental Neuroscience 20 (2-3): 154-63. Go to original source...
    22. Corbett R., Camacho F., Woods A.T., Kerman L.L., Fishkin R.J., Brooks K., Dunn R.W. (1995). "Antipsychotic Agents Antagonize Non-Competitive N-Methyl-D-Aspartate Antagonist-Induced Behaviors." Psychopharmacology 120 (1): 67-74. Go to original source...
    23. Daenen E.W., Wolterink G., Van Der Heyden J.A., Kruse C.G., Van Ree J.M. (2003). "Neonatal Lesions in the Amygdala or Ventral Hippocampus Disrupt Prepulse Inhibition of the Acoustic Startle Response; Implications for an Animal Model of Neurodevelopmental Disorders like Schizophrenia." European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 13 (3): 187-97. Go to original source...
    24. Dingledine R., Borges K., Bowie D., Traynelis S.F. (1999). "The Glutamate Receptor Ion Channels." Pharmacological Reviews 51 (1): 7-61.
    25. Duncan G., Miyamoto S., Gu H., Lieberman J., Koller B., Snouwaert J. (2002). "Alterations in Regional Brain Metabolism in Genetic and Pharmacological Models of Reduced NMDA Receptor Function." Brain Research 951 (2): 166-76. Go to original source...
    26. Duncan G.E., Moy S.S., Lieberman J.A., Koller B.H. (2006a). "Effects of Haloperidol, Clozapine, and Quetiapine on Sensorimotor Gating in a Genetic Model of Reduced NMDA Receptor Function." Psychopharmacology 184 (2): 190-200. Go to original source...
    27. Duncan G.E., Moy S.S., Lieberman J.A., Koller B.H. (2006b). "Typical and Atypical Antipsychotic Drug Effects on Locomotor Hyperactivity and Deficits in Sensorimotor Gating in a Genetic Model of NMDA Receptor Hypofunction." Pharmacology, Biochemistry, and Behavior 85 (3): 481-91. Go to original source...
    28. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., Snouwaert J.N., Koller B.H. (2004). "Deficits in Sensorimotor Gating and Tests of Social Behavior in a Genetic Model of Reduced NMDA Receptor Function." Behavioural Brain Research 153 (2): 507-19. Go to original source...
    29. Egerton A., Reid L., McKerchar C.E., Morris B.J., Pratt J.A. (2005). "Impairment in Perceptual Attentional Set-Shifting Following PCP Administration: A Rodent Model of Set-Shifting Deficits in Schizophrenia." Psychopharmacology 179 (1): 77-84. Go to original source...
    30. Ellison G., Nielsen E.B., LyonM. (1981). "Animal Model of Psychosis: Hallucinatory Behaviors in Monkeys during the Late Stage of Continuous Amphetamine Intoxication." Journal of Psychiatric Research 16 (1): 13-22. Go to original source...
    31. Fride E., Weinstock M. (1988). "Prenatal Stress Increases Anxiety Related Behavior and Alters Cerebral Lateralization of Dopamine Activity." Life Sciences 42 (10): 1059-65. Go to original source...
    32. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., Tamminga C.A. (2000). "Ionotropic Glutamate Receptors and Expression of N-Methyl-D-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia." The American Journal of Psychiatry 157 (7): 1141-49. Go to original source...
    33. Genius J., Geiger J., Dölzer A.L., Benninghoff J., Giegling I., Hartmann A.M., Möller H.J., Rujescu D. (2013). "Glutamatergic Dysbalance and Oxidative Stress in in Vivo and in Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism." PloS One 8 (7): e59395. Go to original source...
    34. Gerlai R., Pisacane P., Erickson S. (2000). "Heregulin, but Not ErbB2 or ErbB3, Heterozygous Mutant Mice Exhibit Hyperactivity in Multiple Behavioral Tasks." Behavioural Brain Research 109 (2): 219-27. Go to original source...
    35. Ghoneim M.M., Hinrichs J.V., Mewaldt S.P., Petersen R.C. (1985). "Ketamine: Behavioral Effects of Subanesthetic Doses." Journal of Clinical Psychopharmacology 5 (2): 70-77. Go to original source...
    36. Gorter J.A., de Bruin J.P. (1992). "Chronic Neonatal MK-801 Treatment Results in an Impairment of Spatial Learning in the Adult Rat." Brain Research 580 (1-2): 12-17. Go to original source...
    37. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgman-Winter K.E., Siegel S.J., Gallop R.J., Arnold S.E. (2006). "Altered Neuregulin 1-erbB4 Signaling Contributes to NMDA Receptor Hypofunction in Schizophrenia." Nature Medicine 12 (7): 824-28. Go to original source...
    38. Han K., Kim I.Y., Kim J.J. (2012). "Assessment of Cognitive Flexibility in Real Life Using Virtual Reality: A Comparison of Healthy Individuals and Schizophrenia Patients." Computers in Biology and Medicine 42 (8): 841-47. Go to original source...
    39. Harris L.W., Sharp T., Gartlon J., Jones D.N., Harrison P.J. (2003). "Long-Term Behavioural, Molecular and Morphological Effects of Neonatal NMDA Receptor Antagonism." The European Journal of Neuroscience 18 (6): 1706-10. Go to original source...
    40. Harrison P.J., Pritchett D., Stumpenhorst K., Betts J.F., Nissen W., Schweimer J., Lane T., Burnet P.W., Lamsa K.P., Sharp T., Bannerman D.M., Tunbridge E.M. (2012). "Genetic Mouse Models Relevant to Schizophrenia: Taking Stock and Looking Forward." Neuropharmacology 62 (3): 1164-67. Go to original source...
    41. Hauber W., Schmidt W.J. (1989). "Effects of Intrastriatal Blockade of Glutamatergic Transmission on the Acquisition of T-Maze and Radial Maze Tasks." Journal of Neural Transmission. General Section 78 (1): 29-41. Go to original source...
    42. Hetzler B.E., Wautlet B.S. (1985). "Ketamine-Induced Locomotion in Rats in an Open-Field." Pharmacology, Biochemistry, and Behavior 22 (4): 653-55. Go to original source...
    43. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., Mei L. (2000). "Regulation of Neuregulin Signaling by PSD-95 Interacting with ErbB4 at CNS Synapses." Neuron 26 (2): 443-55. Go to original source...
    44. Jablensky A. (2000). "Epidemiology of Schizophrenia: The Global Burden of Disease and Disability." European Archives of Psychiatry and Clinical Neuroscience 250 (6): 274-85. Go to original source...
    45. Jaskiw G.E., Karoum F., Freed W.J., Phillips I., Kleinman J.E., Weinberger D.R. (1990). "Effect of Ibotenic Acid Lesions of the Medial Prefrontal Cortex on Amphetamine-Induced Locomotion and Regional Brain Catecholamine Concentrations in the Rat." Brain Research 534 (1-2): 263-72. Go to original source...
    46. Javitt D.C., Zukin S.R. (1991). "Recent Advances in the Phencyclidine Model of Schizophrenia." The American Journal of Psychiatry 148 (10): 1301-8. Go to original source...
    47. Jones C.A., Watson D.J. Fone K.C. (2011). "Animal Models of Schizophrenia." British Journal of Pha rmacology 164 (4): 1162-94. Go to original source...
    48. Kalinichev M., Robbins M.J., Hartfield E.M., Maycox P.R., Moore S.H., Savage K.M., Austin N.E., Jones D.N. (2008). "Comparison between Intraperitoneal and Subcutaneous Phencyclidine Administration in Sprague -Dawley Rats: A Locomotor Activity and Gene Induction Study." Progress in Neuro-Psychopharmacology & Biological Psychiatry 32 (2): 414-22. Go to original source...
    49. Kapur S., Seeman P. (2002). "NMDA Receptor Antagonists Ketamine and PCP Have Direct Effects on the Dopamine D(2) and Serotonin 5-HT(2)receptors-Implications for Models of Schizophrenia." Molecular Psychiatry 7 (8): 837-44. Go to original source...
    50. Kew J.N., Koester A., Moreau J.L., Jenck F., Ouagazzal A.M., Mutel V., Richards J.G., Trube G., Fischer G., Montkowski A., Hundt W., Reinscheid R.K., Pauly-Evers M., Kemp J.A., Bluethmann H. (2000). "Functional Consequences of Reduction in NMDA Receptor Glycine Affinity in Mice Carrying Targeted Point Mutations in the Glycine Binding Site." The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 20 (11): 4037-49. Go to original source...
    51. Koek W., Woods J.H., Winger G.D. (1988). "MK-801, a Proposed Noncompetitive Antagonist of Excitatory Amino Acid Neurotransmission, Produces Phencyclidine-like Behavioral Effects in Pigeons, Rats and Rhesus Monkeys." The Journal of Pharmacology and Experimental Therapeutics 245 (3): 969-74.
    52. Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H. (1995). "Domain Interaction between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95." Science (New York, N.Y.) 269 (5231): 1737-40. Go to original source...
    53. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers Jr M.B., Charney D. S. (1994). "Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans. Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses." Archives of General Psychiatry 51 (3): 199-214. Go to original source...
    54. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. (1995). "Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia." Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 13 (1): 9-19. Go to original source...
    55. Lee H., Choi B.H. (1992). "Density and Distribution of Excitatory Amino Acid Receptors in the Developing Human Fetal Brain: A Quantitative Autoradiographic Study." Experimental Neurology 118 (3): 284-90. Go to original source...
    56. Li H.B., Matsumoto K., Yamamoto M., Watanabe H. (1997). "NMDA but Not AMPA Receptor Antagonists Impair the Delay-Interposed Radial Maze Performance of Rats." Pharmacology, Biochemistry, and Behavior 58 (1): 249-53. Go to original source...
    57. Li J.T., Feng Y., Su Y.A., Wang X.D., Si T.M. (2013). "Enhanced Interaction among ErbB4, PSD-95 and NMDAR by Chronic MK-801 Treatment Is Associated with Behavioral Abnormalities." Pharmacology Biochemistry and Behavior 108 (July): 44-53. Go to original source...
    58. Lillrank S.M., Lipska B.K., Bachus S.E., Wood G.K., Weinberger D.R. (1996). "Amphetamine-Induced c-Fos mRNA Expression Is Altered in Rats with Neonatal Ventral Hippocampal Damage." Synapse (New York, N.Y.) 23 (4): 292-301. Go to original source...
    59. Linn G.S., Javitt D.C. (2001). "Phencyclidine (PCP)-Induced Deficits of Prepulse Inhibition in Monkeys." Neuroreport 12 (1): 117-20. Go to original source...
    60. Lipska B.K. (2004). "Using Animal Models to Test a Neurodevelopmental Hypothesis of Schizophrenia." Journal of Psychiatry & Neuroscience: JPN 29 (4): 282-86.
    61. Lipska B.K., Aultman J.M., Verma A., Weinberger D.R., Moghaddam B. (2002a). "Neonatal Damage of the Ventral Hippocampus Impairs Working Memory in the Rat." Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 27 (1): 47-54.. Go to original source...
    62. Lipska B.K., Halim N.D., Segal P.N., Weinberger D.R. (2002b). "Effects of Reversible Inactivation of the Neonatal Ventral Hippocampus on Behavior in the Adult Rat." The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 22 (7): 2835-42. Go to original source...
    63. Lipska B.K., Jaskiw G.E., Weinberger D.R. (1993). "Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia." Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 9 (1): 67-75. Go to original source...
    64. Lipska B.K., Weinberger D.R. (1993). "Delayed Effects of Neonatal Hippocampal Damage on Haloperidol - Induced Catalepsy and Apomorphine-Induced Stereotypic Behaviors in the Rat." Brain Research. Developmental Brain Research 75 (2): 213-22. Go to original source...
    65. Lipska B.K., Weinberger D.R. (1995). "Genetic Variation in Vulnerability to the Behavioral Effects of Neonatal Hippocampal Damage in Rats." Proceedings of the National Academy of Sciences of the United States of America 92 (19): 8906-10. Go to original source...
    66. Llorente R., Arranz L., Marco E.M., Moreno E., Puerto M., Guaza C.,De la Fuente M., Viveros M.P. (2007). "Early Maternal Deprivation and Neonatal Single Administration with a Cannabinoid Agonist Induce Long-Term Sex-Dependent Psychoimmunoendocrine Effects in Adolescent Rats." Psychoneuroendocrinology 32 (6): 636-50. Go to original source...
    67. Lobellova V., Entlerova M., Svojanovska B., Hatalova H., Prokopova I., Petrasek T., Vales K., Kubik S., Fajnerova I., Stuchlik A. (2013). "Two Learning Tasks Provide Evidence for Disrupted Behavioural Flexibility in an Animal Model of Schizophrenia-like Behaviour Induced by Acute MK-801: A Dose-Response Study." Behavioural Brain Research 246 (June): 55-62. Go to original source...
    68. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., Roder J.C. (1997). "Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) but Normal CA3 LTP." The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 17 (13): 5196-5205. Go to original source...
    69. Lukoyanov N.V., Paula-Barbosa M.M. (2000). "A Single High Dose of Dizocilpine Produces Long-Lasting Impairment of the Water Maze Performance in Adult Rats." Neuroscience Letters 285 (2): 139-42. Go to original source...
    70. Malhotra A.K., Adler C.M., Kennison S.D., Elman I., Pickar D., Breier A. (1997). "Clozapine Blunts N-Methyl-D-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine." Biological Psychiatry 42 (8): 664-68. Go to original source...
    71. Mansbach R.S., Geyer M.A. (1989). "Effects of Phencyclidine and Phencyclidine Biologs on Sensorimotor Gating in the Rat." Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2 (4): 299-308. Go to original source...
    72. Moghaddam B., Adams B., Verma A., Daly D. (1997). "Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex." The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 17 (8): 2921-27. Go to original source...
    73. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. (1999). "Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia." Cell 98 (4): 427-36. Go to original source...
    74. Nabeshima T., Yamaguchi K., Furukawa H., Kameyama T. (1984). "Role of Sex Hormones in Sex -Dependent Differences in Phencyclidine-Induced Stereotyped Behaviors in Rats." European Journal of Pharmacology 105 (3-4): 197-206. Go to original source...
    75. Nilsson M., Waters S., Waters N., Carlsson A., Carlsson M.L. (2001). "A Behavioural Pattern Analysis of Hypoglutamatergic Mice-Effects of Four Different Antipsychotic Agents." Journal of Neural Transmission (Vienna, Austria: 1996) 108 (10): 1181-96. Go to original source...
    76. Nishiguchi N., Shirakawa O., Ono H., Hashimoto T., Maeda K. (2000). "Novel Polymorphism in the Gene Region Encoding the Carboxyl-Terminal Intracellular Domain of the NMDA Receptor 2B Subunit: Analysis of Association with Schizophrenia." The American Journal of Psychiatry 157 (8): 1329-31. Go to original source...
    77. Noda Y., Yamada K., Furukawa H., Nabeshima T. (1995). "Enhancement of Immobility in a Forced Swimming Test by Subacute or Repeated Treatment with Phencyclidine: A New Model of Schizophrenia." British Journal of Pharmacology 116 (5): 2531-37. Go to original source...
    78. Ohno M., Watanabe S. (1996). "Interactive Processing between Glutamatergic and Cholinergic Systems Involved in Inhibitory Avoidance Learning of Rats." European Journal of Pharmacology 312 (2): 145-47. Go to original source...
    79. Olney J.W., Farber NB. (1995). "Glutamate Receptor Dysfunction and Schizophrenia." Archives of General Psychiatry 52 (12): 998-1007. Go to original source...
    80. Olney J.W., Labruyere J., Price M.T. (1989). "Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs." Science (New York, N.Y.) 244 (4910): 1360-62. Go to original source...
    81. Papaleo F., Lipska B.K., Weinberger D.R. (2012). "Mouse Models of Genetic Effects on Cognition: Relevance to Schizophrenia." Neuropharmacology 62 (3): 1204-20. Go to original source...
    82. Pitkänen M., Sirviö J., MacDonald E., Niemi S., Ekonsalo T., Riekkinen Sr P. (1995). "The Effects of D -Cycloserine and MK-801 on the Performance of Rats in Two Spatial Learning and Memory Tasks." European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 5 (4): 457-63. Go to original source...
    83. Pulver A.E., Lasseter V.K., Kasch L., Wolyniec P., Nestadt G., Blouin J.L., Kimberland M., Babb R., Vourlis S., Chen H. (1995). "Schizophrenia: A Genome Scan Targets Chromosomes 3p and 8p as Potential Sites of Susceptibility Genes." American Journal of Medical Genetics 60 (3): 252-60. Go to original source...
    84. Ridley R.M., Baker H.F., Owen F., Cross A.J., Crow T.J. (1982). "Behavioural and Biochemical Effects of Chronic Amphetamine Treatment in the Vervet Monkey." Psychopharmacology 78 (3): 245-51. Go to original source...
    85. Rosso I.M., Bearden C.E., Hollister J.M., Gasperoni T.L., Sanchez L.E., Hadley T., Cannon T.D. (2000). "Childhood Neuromotor Dysfunction in Schizophrenia Patients and Their Unaffected Siblings: A Prospective Cohort Study." Schizophrenia Bulletin 26 (2): 367-78. Go to original source...
    86. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., Giegling I., Genius J., McCarley R.W., Möller H.J., Grunze H. (2006). "A Pharmacological Model for Psychosis Based on N-Methyl-D-Aspartate Receptor Hypofunction: Molecular, Cellular, Functional and Behavioral Abnormalities." Biological Psychiatry 59 (8): 721-29. Go to original source...
    87. Sams-Dodd F., Lipska B.K., Weinberger D.R. (1997). "Neonatal Lesions of the Rat Ventral Hippocampus Result in Hyperlocomotion and Deficits in Social Behaviour in Adulthood." Psychopharmacology 132 (3): 303-10. Go to original source...
    88. Sartorius N., Jablensky A., Korten A., Ernberg G., Anker M., Cooper J.E., Day R. (1986). "Early Manifestations and First-Contact Incidence of Schizophrenia in Different Cultures. A Preliminary Report on the Initial Evaluation Phase of the WHO Collaborative Study on Determinants of Outcome of Severe Mental Disorders." Psychological Medicine 16 (4): 909-28. Go to original source...
    89. Schmid R.S., McGrath B., Berechid B.E., Boyles B., Marchionni M., Sestan N., Anton E.S. (2003). "Neuregulin 1-erbB2 Signaling Is Required for the Establishment of Radial Glia and Their Transformation into Astrocytes in Cerebral Cortex." Proceedings of the National Academy of Sciences of the United States of America 100 (7): 4251-56. Go to original source...
    90. Schmitt A., Fendt M., Zink M., Ebert U., Starke M., Berthold M., Herb A., Petroianu G., Falkai P., Henn F.A. (2007). "Altered NMDA Receptor Expression and Behavior Following Postnatal Hypoxia: Potential Relevance to Schizophrenia." Journal of Neural Transmission (Vienna, Austria: 1996) 114 (2): 239-48. Go to original source...
    91. Seibt K.J., Piato A.L., da Luz Oliveira R., Capiotti K.M., Vianna M.R., Bonan C.D. (2011). "Antipsychotic Drugs Reverse MK-801-Induced Cognitive and Social Interaction Deficits in Zebrafish (Danio Rerio)." Behavioural Brain Research 224 (1): 135-39. Go to original source...
    92. Shiigi Y., Casey D.E. (1999). "Behavioral Effects of Ketamine, an NMDA Glutamatergic Antagonist, in Non -Human Primates." Psychopharmacology 146 (1): 67-72. Go to original source...
    93. Sillito A.M., Murphy P.C., Salt T.E., Moody C.I. (1990). "Dependence of Retinogeniculate Transmission in Cat on NMDA Receptors." Journal of Neurophysiology 63 (2): 347-55. Go to original source...
    94. Sircar R., Rudy J.W. (1998). "Repeated Neonatal Phencyclidine Treatment Impairs Performance of a Spatial Task in Juvenile Rats." Annals of the New York Academy of Sciences 844 (May): 303-9. Go to original source...
    95. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarrson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. (2002). "Neuregulin 1 and Susceptibility to Schizophrenia." American Journal of Human Genetics 71 (4): 877-92. Go to original source...
    96. Stuchlik A., Rezacova L., Vales K., Bubenikova V., Kubik S. (2004). "Application of a Novel Active Allothetic Place Avoidance Task (AAPA) in Testing a Pharmacological Model of Psychosis in Rats: Comparison with the Morris Water Maze." Neuroscience Letters 366 (2): 162-66. Go to original source...
    97. Sturgeon R.D., Fessler R.G., London S.F., Meltzer H.Y. (1981). "A Comparison of the Effects of Neuroleptics on Phencyclidine-Induced Behaviors in the Rat." European Journal of Pharmacology 76 (1): 37-53. Go to original source...
    98. Swerdlow N.R., Bakshi V., Waikar M., Taaid N., Geyer M.A. (1998). "Seroquel, Clozapine and Chlorpromazine Restore Sensorimotor Gating in Ketamine-Treated Rats." Psychopharmacology 140 (1): 75-80. Go to original source...
    99. Swerdlow N.R., Geyer M.A. (1993). "Clozapine and Haloperidol in an Animal Model of Sensorimotor Gating Deficits in Schizophrenia." Pharmacology, Biochemistry, and Behavior 44 (3): 741-44. Go to original source...
    100. Takei N., Murray R.M., Sham P., O'Callaghan E. (1995). "Schizophrenia Risk for Women from in Utero Exposure to Influenza." The American Journal of Psychiatry 152 (1): 150-51. Go to original source...
    101. Tiedtke P.I., Bischoff C., Schmidt W.J. (1990). "MK-801-Induced Stereotypy and Its Antagonism by Neuroleptic Drugs." Journal of Neural Transmission. General Section 81 (3): 173-82. Go to original source...
    102. Vaskovsky A.,Lupowitz Z., Erlich S., Pinkas-Kramarski R. (2000). "ErbB-4 Activation Promotes Neurite Outgrowth in PC12 Cells." Journal of Neurochemistry 74 (3): 979-87. Go to original source...
    103. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J.L., Johnson K.M. (2001). "Long-Term Behavioral and Neurodegenerative Effects of Perinatal Phencyclidine Administration: Implications for Schizophrenia." Neuroscience 107 (4): 535-50. Go to original source...
    104. Whishaw I.Q., Auer R.N. (1989). "Immediate and Long-Lasting Effects of MK-801 on Motor Activity, Spatial Navigation in a Swimming Pool and EEG in the Rat." Psychopharmacology 98 (4): 500-507. Go to original source...
    105. White A.M., Best P.J. (1998). "The Effects of MK-801 on Spatial Working Memory and within-Session Spatial Learning." Pharmacology, Biochemistry, and Behavior 59 (3): 613-17. Go to original source...
    106. Willi R., Weinmann O., Winter C., Klein J., Sohr R., Schnell L., Yee B.K., Feldon J., Schwab M.E. (2010). "Constitutive Genetic Deletion of the Growth Regulator Nogo-A Induces Schizophrenia-Related Endophenotypes." The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 30 (2): 556-67. Go to original source...
    107. Zemanova A., Stankova A., Lobellova V., Svoboda J., Vales K., Vlcek K., Kubik S., Fajnerova I, Stuchlik A. (2013). "Visuospatial Working Memory Is Impaired in an Animal Model of Schizophrenia Induced by Acute MK -801: An Effect of Pretraining." Pharmacology, Biochemistry, and Behavior 106 (May): 117-23. Go to original source...
    108. Zhang Z.J., Reynolds G.P. (2002). "A Selective Decrease in the Relative Density of Parvalbumin-Immunoreactive Neurons in the Hippocampus in Schizophrenia." Schizophrenia Research 55 (1-2): 1-10. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content